About HadasitHadasit, the Technology Transfer Company of Hadassah Medical Organization in Jerusalem, promotes and commercializes HMO continuously generated intellectual property and R & D capabilities. IP generated by HMO has already gained global recognition through Hadasit successful entrepreneurial Hadassah’s biomedical technology, including novel therapeutics, diagnostics and devices.
Hadasit users will contribute specific methods for the treatment of immune-mediated disorders, and cancer. Hadasit is vast pool of huge pool of IP, it also has a reputation as a center for preclinical and early phase clinical practice their clinical performance, integrity, and overall commitment to creating therapeutics that will have a positive global to be effective to be effective with Hadasit a natural choice, Dr. Oren Fuerst, VP business development at Anadis and CEO of Immuron. The philosophy that in the next five years, the competitive landscape of biotherapy is changed completely, with our new venture playing a central role. .. The products are of of intellectual property from Hadasit and Anadis. Read the rest of this entry »